99% Savings - Buy Just @1 Rs X
Bromocriptine + Metformin is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Bromocriptine + Metformin is used -
Severe
Moderate
Mild
Common
Is the use of Bromocriptine + Metformin safe for pregnant women?
Bromocriptine + Metformin has little to no side effects in pregnant women.
Is the use of Bromocriptine + Metformin safe during breastfeeding?
Bromocriptine + Metformin should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Bromocriptine + Metformin on the Kidneys?
Bromocriptine + Metformin has very mild side effects on the kidneys.
What is the effect of Bromocriptine + Metformin on the Liver?
Very few cases of side effects of Bromocriptine + Metformin on the liver have been reported.
What is the effect of Bromocriptine + Metformin on the Heart?
Bromocriptine + Metformin can cause side effects that could harm the heart. So medical advice before taking it is necessary.
Bromocriptine + Metformin should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Bromocriptine + Metformin unless your doctor advises you to do so -
Is this Bromocriptine + Metformin habit forming or addictive?
Bromocriptine + Metformin is not addictive in nature.
Interaction between Food and Bromocriptine + Metformin
Due to a lack of research, nothing can be said about the consequences of taking Bromocriptine + Metformin together with food.
Interaction between Alcohol and Bromocriptine + Metformin
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Bromocriptine + Metformin.
Yes, you can take Bromocriptine + Metformin with a beta-blocker. People with diabetes tend to develop heart disease or stroke at an earlier age than the general population. One reason for this is that high glucose levels increase your risk of high blood pressure (hypertension). No harmful interactions are seen between them. However, a recent study suggests that beta-blockers can decrease the plasma level of Bromocriptine + Metformin and long-term use can increase lactic acid and uric acid in the blood.
Bromocriptine + Metformin is used with a proper diet and exercise program, to treat diabetes. It is also used with other medication to reduce the high blood sugar. It is used in a patient with type2 diabetes. It is also used in the treatment of polycystic ovarian syndrome (PCOS) and cancer.
Bromocriptine + Metformin is not a known cause of alopecia (hair loss). However, the conditions treated by Bromocriptine + Metformin type 2 diabetes and PCOS, often list hair loss as a possible symptom.
Yes, you can take Bromocriptine + Metformin with gliclazide, no harmful interactions have been reported between them. However, it is not necessary that no interaction can happen between these two. But before taking such kind of combination you must consult your doctor.
Yes, Bromocriptine + Metformin can cause some sleep problems, especially insomnia. On the other hand, Bromocriptine + Metformin has proven to be useful for preventing sleep apnea. The exact relationship between Bromocriptine + Metformin and sleep problems is still not clear, and further studies are needed for a clearer understanding.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 176
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Parlodel® (bromocriptine mesylate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Kripton (bromocriptine mesylate)